The Dow Jones closed higher by more than 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Genasys
- The Trade: Genasys Inc. GNSS Director Richard Osgood acquired a total of 50,000 shares an average price of $2.00. To acquire these shares, it cost around $100,000.
- What’s Happening: Genasys announced a $1 million contract with the U.S. Army to design and build the first CROWS-AHD prototypes.
- What Genasys Does: Genasys Inc is a provider of critical communications solutions designed to help keep people safe.
NetSol Technologies
- The Trade: NetSol Technologies, Inc. NTWK CEO Najeeb Ghauri acquired a total of 4,000 shares at an average price of $1.93. To acquire these shares, it cost around $7,709.
- What’s Happening: NETSOL Technologies reported a year-over-year decrease in fourth-quarter EPS results and issued FY24 revenue guidance.
- What NetSol Technologies Does: NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others.
Check This Out: AZZ, Richardson Electronics And 3 Stocks To Watch Heading Into Wednesday
Sportsman's Warehouse
- The Trade: Sportsman's Warehouse Holdings, Inc. SPWH Director Richard McBee acquired a total of 5,039 shares at an average price of $3.97. The insider spent $19,985 to buy those shares.
- What’s Happening: Sportsman's Warehouse reported worse-than-expected second-quarter earnings.
- What Sportsman's Warehouse Does: Sportsman's Warehouse Holdings Inc together with its subsidiaries operates as an outdoor sporting goods retailer.
Journey Medical
- The Trade: Journey Medical Corporation DERM Director Jeffrey Paley acquired a total of 15,000 shares at an average price of $2.98. The insider spent around $44,700.
- What’s Happening: Journey Medical entered into exclusive license agreement with Maruho Co., Ltd. for Qbrexza in South Korea and other Asian nations.
- What Journey Medical Does: Journey Medical Corp is a commercial-stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions.
Don’t forget to check out our premarket coverage here
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.